Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ProSomnus, Inc. - Common Stock
(NQ:
OSA
)
0.4700
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ProSomnus, Inc. - Common Stock
< Previous
1
2
Next >
ProSomnus® Appoints Brian Dow as Chief Financial Officer
March 01, 2023
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus® Provides Business Update and Preliminary 2022 Revenue Guidance
February 01, 2023
Company commences execution of strategic growth initiatives following Initial Public Offering
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus® Announces Acceptance of Abstract for Oral Presentation at Prestigious American Thoracic Society 2023 International Conference
January 26, 2023
Data from First Line Obstructive Sleep Apnea Treatment Study (FLOSAT) study will be presented for the first time
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus® Announces Completion of Enrollment in Antwerp University Hospital’s First Line Obstructive Sleep Apnea Treatment Study (FLOSAT)
December 21, 2022
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus® Enrolls First Participant in Study Evaluating Safety and Efficacy of ProSomnus EVO™ in Treating Severe Obstructive Sleep Apnea
December 19, 2022
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus® Announces Medicare Reimbursement for ProSomnus EVO® [PH] Sleep Apnea and Snoring Device
December 15, 2022
Additional reimbursement coverage further expands the market for ProSomnus as the Company seeks to make precision oral appliance therapy a first-line treatment for obstructive sleep apnea
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
Study Published in "Military Medicine" Reports 88% Success Treating Obstructive Sleep Apnea Patients with Precision Oral Appliance Therapy
December 08, 2022
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.